Immune regulation of colitis and associated cancer

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Inflammatory bowel disease is a debilitating condition that can significantly increase the likelihood of developing colon cancer. There are many different cellular pathways that lead to this inflammation, but we have uncovered a key signal that can prevent it from occurring. Specifically, we have identified how this signal increases a new type of suppressive cell that fights inflammation in the colon and can also stop this leading cancer.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $646,995.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Innate Immunity

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

colon cancer | inflammatory bowel disease (IBD) | innate immunity | interleukins (IL) | regulatory T cells